The Lexington Cancer Foundation presented a $1.2 million gift to the UK Markey Cancer Center, completing the organization’s $5 million commitment to the UK Cancer and Advanced Ambulatory Building.
People diagnosed with cancer during the first two years of the COVID-19 pandemic had lower survival rates than those diagnosed in the years before, according to a UK Markey Cancer Center study.
Research has shown that for patients with stage IV cancer, adding procedures to destroy or remove specific tumors can improve outcomes when combined with systemic therapies like chemotherapy.
UK Markey Cancer Center is the first site in the country to open a clinical trial for ZG006, an experimental drug that works by connecting disease-fighting T cells to cancer cells.
Collaboration between the UK Sanders-Brown Center on Aging, Markey Cancer Center and the Department of Radiology is changing how Alzheimer’s disease and related dementias are detected, understood and treated.
A UK Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in bone tissue, offering a potential new treatment target for patients with advanced disease.
Markey is one of only 57 NCI-designated Comprehensive Cancer Centers in the country and remains a national leader in advancing research, precision oncology and equitable access to care.
